NASDAQ · Financial Statements

Phoenix Biotech Acquisition Corp. (PBAX) Financial Statements

$5.85 NASDAQ: PBAX Market Cap $36.47M

Phoenix Biotech Acquisition Corp. most recently reported annual revenue of $0, a net loss of $96.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric2021202220242025
Revenue$0$0$0$0
Operating Profit$0$0$-16.0M$-18.0M
Net Profit$0$-1.0M$-11.0M$-96.0M
EPS$0.00$-0.01$-0.22$-22.58
Op Margin————

Balance Sheet (USD)

Metric2021202220242025
Total Assets$180.0M$42.0M$6.0M$4.0M
Total Liabilities$9.0M$40.0M$8.0M$9.0M
Cash$1.0M$0$3.0M$2.0M
Borrowings$0$1.0M$2.0M$1.0M

Cash Flow (USD)

Metric2021202220242025
Operating Cash Flow$-1.0M$-1.0M$-6.0M$-16.0M
Investing Cash Flow$-178.0M$181.0M$0$1.0M
Financing Cash Flow$180.0M$-278.0M$1.0M$14.0M
Net Cash Flow$1.0M$41.0M$-5.0M$-2.0M
Free Cash Flow$-1.0M$-1.0M$-6.0M$-16.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-1.25
FCF Yield-39.47%
Quick Ratio0.14
Interest Coverage118.04
Return 1Y—
Return 3Y—
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Financial Services StocksLow P/E Financial Services StocksHigh Net Margin Financial Services StocksDividend Financial Services StocksLow Debt Financial Services StocksNasdaq High ROE StocksAll stock screens
PBAX Overview PBAX Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.